雪榕生物: 上海雪榕生物科技股份有限公司第五届董事会第三十次会议决议公告

Group 1 - The company held its 30th meeting of the 5th board of directors, which was conducted both in-person and via electronic communication [1] - The board approved the establishment of Chengdu Xuecao Biotechnology Co., Ltd. in collaboration with Qinghai Chenxin Biotechnology Co., Ltd. and Mr. Zheng Weidong to enhance production capacity and optimize product structure [1][2] - Chengdu Xuecao will focus on the research, cultivation, and sales of Cordyceps sinensis, with a registered capital of 20 million yuan [2] Group 2 - Chengdu Xuelong will contribute 10.2 million yuan, accounting for 51% of the registered capital, while Chenxin Biotechnology will contribute 7 million yuan (35%) and Mr. Zheng Weidong will contribute 2.8 million yuan (14%) [2] - The investment proposal received unanimous approval from the board members, with 6 votes in favor and no opposition [2] - The company plans to apply for a credit facility of up to 1 billion yuan from China Construction Bank, with the decision also receiving unanimous support from the board [2]